- Conditions
- Agammaglobulinemia, Blood Protein Disorders, Chronic Disease, +18 more
- Locations
-
- Octapharma Research Site St. Petersburg, Florida, United States
- Octapharma Research Site Columbus, Georgia, United States
- Octapharma Research Site Macon, Georgia, United States
- Octapharma Research Site New Orleans, Louisiana, United States
Clinical trial condition
Immunoproliferative Disorders
Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.
10,009 public trials
2,034 recruiting studies
Immunoproliferative Disorders trial results
NCT06224309
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +33 more
- Locations
-
- BC Cancer Vancouver, British Columbia, Canada
Completed
CAR-T for R/R B-NHL
NCT03196830
- Conditions
- CAR - T CD19/CD20/CD22/CD30, Disease Attributes, Hemic and Lymphatic Diseases, +13 more
- Locations
-
- the First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China
NCT00534430
- Conditions
- Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +27 more
- Locations
-
Not specified
NCT04923789
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China
Completed
A Clinical Trial of TQ05105 Tablets in the Treatment of Moderate and High Risk Myelofibrosis
NCT05020652
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- Peking Union Medical College Hospital Beijing, Beijing Municipality, China
- Guangdong Provincial Peoples Hospital Guangzhou, Guangdong, China
- West China School of Medicine / West China Hospital, Sichuan University Chengdu, Sichuan, China
- Institute of Hematology & Blood Diseases Hostpital, Chinese Academy of medical sciences & Peking Union Medical College Tianjin, Tianjin Municipality, China
NCT02883049
- Conditions
- B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia, BCR-ABL1-Like, Burkitt Lymphoma, +18 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- USA Health Strada Patient Care Center Mobile, Alabama, United States
- Providence Alaska Medical Center Anchorage, Alaska, United States
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Innovative Clinical Research Inc Cerritos, California, United States
- Baptist MD Anderson Jacksonville, Florida, United States
- Fort Wayne Medical Oncology and Hematology, Inc. Fort Wayne, Indiana, United States
- Norton Healthcare Louisville, Kentucky, United States
Completed
A Study of CD19/22 CART Cells Combined With PD-1 Inhibitor in Relapsed/Refractory B-cell Lymphoma
NCT04539444
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
- Locations
-
- The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China
NCT05322330
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China